/People

Steve Jackson

Investor

Founding Partner at Ahren Innovation Capital

Minnetonka, Minnesota, United States

Writes $100K – $5M checks · typically $1.5M

Find your path to Steve

Sign up to see every warm intro you have to Steve

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Steve. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Founding Partner and originator of the cancer drug Olaparib/Lynparza. Repeat entrepreneur who co-founded Adrestia Therapeutics with Ahren in 2018; Professor of Biology at Cambridge and a Fellow of the Royal Society.

Invests in

AI & Machine LearningBiotechClimate TechDeep TechHardwareRobotics

Colleagues at Ahren Innovation Capital

Frequently asked questions

Who is Steve Jackson?
Founding Partner and originator of the cancer drug Olaparib/Lynparza. Repeat entrepreneur who co-founded Adrestia Therapeutics with Ahren in 2018; Professor of Biology at Cambridge and a Fellow of the Royal Society.
Where does Steve Jackson work?
Steve Jackson is Founding Partner at Ahren Innovation Capital.
What does Steve Jackson invest in?
Steve Jackson invests in AI & Machine Learning, Biotech, Climate Tech, Deep Tech, Hardware, Robotics.
What check size does Steve Jackson write?
Steve Jackson typically writes checks of $100K – $5M.

Founder mafias

About this profile. Compiled from public sources — Ahren Innovation Capital's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights